Matthew R. Kane, President and CEO at PRECISION BIOSCIENCES INC (DTIL), sold 38,842 shares at $11.79 ($450K) on 2021-03-10, disclosed to the SEC on 2021-03-12.
Open-market sale of $450k DTIL by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.79 | 9,710 | $114K | 25.4% |
| 2 | $11.79 | 9,710 | $114K | 25.4% |
| 3 | $11.38 | 9,711 | $111K | 24.6% |
| 4 | $11.38 | 9,711 | $111K | 24.6% |
| Total | $11.58 avg | 38,842 | $450K | 100% |
| Filing → |
| DTIL | SELL | 2021-04-14 | $169K | — | Filing → |
| DTIL | SELL | 2021-04-12 | $260K | — | Filing → |
| DTIL | SELL | 2021-03-16 | $221K | — | Filing → |